
Roche saw its business grow in the first three months of the year, thanks to strong showings from hepatitis C …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

